兰索拉唑肠溶胶囊、多潘立酮片联合加味逍遥颗粒治疗癔球症临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R749.7+3

基金项目:


Clinical Study on Lansoprazole Enteric-Coated Capsules and Domperidone Combined with Modified Xiaoyao Granules for Globus Sensation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察兰索拉唑肠溶胶囊、多潘立酮片联合加味逍遥颗粒对癔球症临床症状、心理状况和生活质量的影响。方 法:对 49 例符合罗马Ⅲ及Ⅳ标准的癔球症患者予兰索拉唑肠溶胶囊、多潘立酮片联合加味逍遥颗粒治疗,采用疗效评估、焦虑自评量表(SAS)、抑郁自评量表(SDS)、汉化版简明健康调查量表(SF-36)评定患者治疗前后临床症状、心理状况和生活质量的改善情况。结果:治疗 4 周后患者临床症状不同程度改善。临床疗效总有效率 81.63%,SF-36 量表 8 个维度的评分均升高;治疗后 SAS 量表评分和 SDS 量表评分亦降低,差异均有统计学意义 (P<0.01)。结论:兰索拉唑肠溶胶囊、多潘立酮片联合加味逍遥颗粒治疗癔球症,不仅改善临床症状,缓解焦虑、抑郁情绪,还可提高患者的生活质量。

    Abstract:

    Abstract:Objective:To observe the effect of lansoprazole enteric- coated capsules and domperidone combined with modified Xiaoyao granules on clinical symptoms,psychological state and quality of life of globus sensation. Methods:A total of 49 cases of patients with globus sensation who met the Rome III and IV criteria were treated with lansoprazole entericcoated capsules and domperidone combined with modified Xiaoyao granules. Before and after treatment,the improvement of clinical symptoms,psychological state and quality of life was evaluated by therapeutic evaluation,Self- rating Anxiety Scale(SAS),Self-rating Depression Scale(SDS) and 36-Item Short Form Health Survey(SF-36). Results:The total effective rate of clinical effect was 81.63%. After four-weeks treatment,the clinical symptoms of patients were improved differently. The scores of the eight dimensions in SF-36 were increased;the scores of SAS and SDS after treatment were decreased, differences being significant(P<0.01). Conclusion:The therapy of lansoprazole enteric- coated capsules and domperidone combined with modified Xiaoyao granules for globus sensation can not only improve clinical symptoms and relieve anxiety and depression,but also improve the quality of life

    参考文献
    相似文献
    引证文献
引用本文

兰巧丽,王英,翁雪健,叶毅.兰索拉唑肠溶胶囊、多潘立酮片联合加味逍遥颗粒治疗癔球症临床研究[J].新中医,2020,52(23):64-65

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-12-09
  • 出版日期: